MRC1 and cancer: The identification of two somatic MMR mutations that explain absent IHC results (i.e. lack of protein staining), in the absence of a germline mutation in that gene, can drastically change a patient’s management from that of an individual with presumed Lynch syndrome and high risk for second primary cancers to that of the average person with a personal history of cancer.